Life Science Developments logo

LIFE - Life Science Developments Share Price

2.38p 0.0  0.0%

Last Trade - 05/10/16

Sector
Basic Materials
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £n/a
Position in Universe th / 1807
Bullish
Bearish
Unlock LIFE Revenue
Momentum
Relative Strength (%)
1m -21.4%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2010 2011 2012 2013 2014 2015 2016E 2017E CAGR / Avg
0.000 -3.29 0.000 0.000 0.000 0.000
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2016, Life Science Developments Ltd revenues was not reported. Net loss increased 18% to $309K. Higher net loss reflects Foreign exchange losses increase from $9K (income) to $82K (expense), Administration Expenses increase of 38% to $65K (expense), Directors fees increase of 21% to $102K (expense). Basic Earnings per Share excluding Extraordinary Items remained flat at -$0.01.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

LIFE Revenue Unlock LIFE Revenue

Net Income

LIFE Net Income Unlock LIFE Revenue

Normalised EPS

LIFE Normalised EPS Unlock LIFE Revenue

PE Ratio Range

LIFE PE Ratio Range Unlock LIFE Revenue

Dividend Yield Range

LIFE Dividend Yield Range Unlock LIFE Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
LIFE EPS Forecasts Unlock LIFE Revenue
Profile Summary

Bradda Head Holdings Ltd, formerly Life Science Developments Limited, is a lithium exploration company focused on developing projects in the United States. Through its subsidiaries, Zenolith (USA) LLC, the Company operates lithium brine, pegmatite and clay projects. The Company’s project includes Burro Creek East, Burro Creek West, Wilson Salt Flat, Spencer and San Domingo. Its Burro Creek East is a lithium clay project located in central western Arizona. The Wilson Salt Flat is a Lithium brine project located in Nye County, Nevada, which is 125 miles east of Clayton Valley and the Silver Peal Lithium brine operation. The Spencer is a lithium brine project; and San Domingo is a lithium pegmatite project located in the Maricopa and Yavapai counties;

Directors
Last Annual December 31st, 2015
Last Interim June 30th, 2016
Incorporated October 28, 2009
Public Since December 13, 2010
No. of Shareholders: n/a
No. of Employees: 61
Sector Basic Materials
Industry Chemicals
Index
Exchange London Stock Exchange
Shares in Issue 37,501,033
Free Float (0.0%)
Eligible for
ISAs
SIPPs
LIFE Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for LIFE
Upcoming Events for LIFE
Frequently Asked Questions for Life Science Developments
What is the Life Science Developments share price?

As of 05/10/16, shares in Life Science Developments are trading at 2.38p, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Life Science Developments share price performed this year?

Shares in Life Science Developments are currently trading at 2.38p and the price has moved by -12.84% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Life Science Developments price has moved by 4.24% over the past year.

What are the analyst and broker recommendations for Life Science Developments?

Of the analysts with advisory recommendations for Life Science Developments, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for Life Science Developments is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will Life Science Developments next release its financial results?

Life Science Developments is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2017-06-30
What is the Life Science Developments dividend yield?

Life Science Developments does not currently pay a dividend.

Does Life Science Developments pay a dividend?

Life Science Developments does not currently pay a dividend.

When does Life Science Developments next pay dividends?

Life Science Developments does not currently pay a dividend.

How do I buy Life Science Developments shares?

To buy shares in Life Science Developments you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Life Science Developments?

Shares in Life Science Developments are currently trading at 2.38p, giving the company a market capitalisation of £n/a.

Where are Life Science Developments shares listed? Where are Life Science Developments shares listed?

Here are the trading details for Life Science Developments:

Country of listing: United Kingdom
Exchange: LSE
Ticker Symbol: LIFE
What kind of share is Life Science Developments?

We were not able to load our ranking data for Life Science Developments

Is there a Life Science Developments share price forecast 2020?

We were not able to load any forecast data for Life Science Developments.

How can I tell whether the Life Science Developments share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Life Science Developments. Over the past six months, the relative strength of its shares against the market has been -37.16%. At the current price of 2.38p, shares in Life Science Developments are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Life Science Developments PE Ratio?

We were not able to find PE ratio data for Life Science Developments.

Who are the key directors of Life Science Developments?

We were unable to find the directors for Life Science Developments.

Who are the major shareholders of Life Science Developments?

Here are the top five shareholders of Life Science Developments based on the size of their shareholding:

Similar to LIFE
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.